254 related articles for article (PubMed ID: 27258253)
61. Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
Sosa Iglesias V; Giuranno L; Dubois LJ; Theys J; Vooijs M
Front Oncol; 2018; 8():267. PubMed ID: 30087852
[TBL] [Abstract][Full Text] [Related]
62. Epigenetic-Metabolic Interplay in the DNA Damage Response and Therapeutic Resistance of Breast Cancer.
Das C; Adhikari S; Bhattacharya A; Chakraborty S; Mondal P; Yadav SS; Adhikary S; Hunt CR; Yadav KK; Pandita S; Roy S; Tainer JA; Ahmed Z; Pandita TK
Cancer Res; 2023 Mar; 83(5):657-666. PubMed ID: 36661847
[TBL] [Abstract][Full Text] [Related]
63. Epigenetic targeting of DNA repair in lung cancer.
Lok BH; Rudin CM
Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22429-22431. PubMed ID: 31662477
[No Abstract] [Full Text] [Related]
64. Genetic determinants for chemo- and radiotherapy resistance in bladder cancer.
Mari A; D'Andrea D; Abufaraj M; Foerster B; Kimura S; Shariat SF
Transl Androl Urol; 2017 Dec; 6(6):1081-1089. PubMed ID: 29354495
[TBL] [Abstract][Full Text] [Related]
65. Epigenetics of lung cancer: a translational perspective.
Quintanal-Villalonga Á; Molina-Pinelo S
Cell Oncol (Dordr); 2019 Dec; 42(6):739-756. PubMed ID: 31396859
[TBL] [Abstract][Full Text] [Related]
66. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment.
Liu YP; Zheng CC; Huang YN; He ML; Xu WW; Li B
MedComm (2020); 2021 Sep; 2(3):315-340. PubMed ID: 34766149
[TBL] [Abstract][Full Text] [Related]
67. The Ribonuclease ZC3H12A is required for self-inflicted DNA breaks after DNA damage in small cell lung cancer cells.
Lu M; Gao Q; Jin R; Gu M; Wang Z; Li X; Li W; Wang J; Ma T
Cell Oncol (Dordr); 2024 Mar; ():. PubMed ID: 38498096
[TBL] [Abstract][Full Text] [Related]
68. Metformin for chemo-radio-sensitization of NSCLC.
Tsakiridis T; Skinner H; Pond G; Swaminath A; Wright J
Radiother Oncol; 2016 Aug; 120(2):363-4. PubMed ID: 27401403
[No Abstract] [Full Text] [Related]
69. Current treatments for non-small cell lung cancer.
Guo Q; Liu L; Chen Z; Fan Y; Zhou Y; Yuan Z; Zhang W
Front Oncol; 2022; 12():945102. PubMed ID: 36033435
[TBL] [Abstract][Full Text] [Related]
70. Lung Cancer: Are we up to the Challenge?
Esposito L; Conti D; Ailavajhala R; Khalil N; Giordano A
Curr Genomics; 2010 Nov; 11(7):513-8. PubMed ID: 21532835
[TBL] [Abstract][Full Text] [Related]
71. Epigenetic regulation of stem cells in lung cancer oncogenesis and therapy resistance.
Wu J; Feng J; Zhang Q; He Y; Xu C; Wang C; Li W
Front Genet; 2023; 14():1120815. PubMed ID: 37144123
[TBL] [Abstract][Full Text] [Related]
72. Natural Compounds That Target DNA Repair Pathways and Their Therapeutic Potential to Counteract Cancer Cells.
Lagunas-Rangel FA; Bermúdez-Cruz RM
Front Oncol; 2020; 10():598174. PubMed ID: 33330091
[TBL] [Abstract][Full Text] [Related]
73. DNA shedding in non-small-cell lung cancer: useful to assess?
Suda K
Lancet Respir Med; 2018 Feb; 6(2):77-78. PubMed ID: 29249324
[No Abstract] [Full Text] [Related]
74. Crude drugs as anticancer agents.
Mou X; Kesari S; Wen PY; Huang X
Int J Clin Exp Med; 2011; 4(1):17-25. PubMed ID: 21394282
[TBL] [Abstract][Full Text] [Related]
75. Editorial: The Role of DNA Repair Pathways in Resistance to Chemotherapy and Radiotherapy in Cancer.
Lee DY; Bermúdez-Cruz RM; Díaz-Chávez J
Front Oncol; 2022; 12():894357. PubMed ID: 35463363
[No Abstract] [Full Text] [Related]
76. Chemotherapy: DNA repair predicts survival in patients with NSCLC.
Hutchinson L
Nat Rev Clin Oncol; 2011 Oct; 8(11):627. PubMed ID: 21989072
[No Abstract] [Full Text] [Related]
77. Targeting DNA damage response systems to impact cancer care.
Mateo J; de Bono JS
Curr Probl Cancer; 2017; 41(4):247-250. PubMed ID: 28583747
[No Abstract] [Full Text] [Related]
78. DNA damage response: Cell thriving despite DNA damage.
Strzyz P
Nat Rev Mol Cell Biol; 2016 Jun; 17(7):396. PubMed ID: 27329962
[No Abstract] [Full Text] [Related]
79. [The role of miRNA in DNA damage response].
Tong Y; Lou JL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Jan; 36(1):74-78. PubMed ID: 29495193
[No Abstract] [Full Text] [Related]
80. Noncoding RNA and colorectal cancer: its epigenetic role.
Kita Y; Yonemori K; Osako Y; Baba K; Mori S; Maemura K; Natsugoe S
J Hum Genet; 2017 Jan; 62(1):41-47. PubMed ID: 27278790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
